Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2024-02-06 Boxer Capital, LLC See Remarks Grant or award +63,412 $13.01 $825K 85,939
2024-02-06 Boxer Capital, LLC See Remarks Grant or award · Warrant (right to purchase) +705,280 $13.01 $9.2M 705,280
2021-12-17 Boxer Capital, LLC 10% owner Purchase +125,000 $13.12 $1.6M 6,448,359
2021-09-17 Boxer Capital, LLC 10% owner Conversion +5,698,359 5,698,359
2021-09-17 Boxer Capital, LLC 10% owner Purchase +625,000 $16.00 $10.0M 6,323,359
2021-09-17 Boxer Capital, LLC 10% owner Conversion +288,095 288,095
2021-09-17 Boxer Capital, LLC 10% owner Conversion · Series A Preferred Stock −1,480,242 0
2021-09-17 Boxer Capital, LLC 10% owner Conversion · Series A Preferred Stock −95,516 0
2021-09-17 Boxer Capital, LLC 10% owner Conversion · Series B Preferred Stock −713,629 0
2021-09-17 Boxer Capital, LLC 10% owner Conversion · Series B Preferred Stock −15,401 0

Page 1 of 1 · 10 trades